In the earliest trial of Moderna’s mRNA-based vaccine, study participants received one of three dose levels: 25, 100 or 250 micrograms. The top dose proved too toxic. The low dose elicited the weakest immune response. The middle dose seemed to offer the best balance: it triggered strong immunity and had acceptable side effects.
That somewhat contradicts the article's claim.
If you under-dose, there may have to be a booster shot. Then the whole inoculation program has to do the job twice.
That somewhat contradicts the article's claim.
If you under-dose, there may have to be a booster shot. Then the whole inoculation program has to do the job twice.